ACE and Hyperkalemia: Prescription of RAAS medications was associated with an increased risk of hyperkalaemia: ACE inhibitors (SHR 1.45, 95% CI 1.42–1.48) and ARBs (SHR 1.27, 95% CI 1.13–1.32).